SRT2104: Clinical Trials

3 trials of SRT2104, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow SRT2104: new trials by email Literature Review of SRT2104 trials Research Report on SRT2104

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
Placebo, SRT2104 - Psoriasis
Phase 2CompletedSirtris, a GSK Company402010-06-072017-10-13
A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus
Placebo, SRT2104 - Diabetes Mellitus, Type 2
Phase 2CompletedGlaxoSmithKline862010-03-032017-04-25
Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
SRT2104, Placebo - Diabetes Mellitus, Type 2
Phase 2CompletedSirtris, a GSK Company2272009-08-192018-07-13

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Psoriasis (1)

Sponsors

Sirtris, a GSK Company (2)  ·  GlaxoSmithKline (1)

Countries

Bulgaria (1)  ·  Estonia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  Ukraine (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 26556603